Pages that link to "Q33793103"
Jump to navigation
Jump to search
The following pages link to Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine (Q33793103):
Displaying 46 items.
- Genome sequence analysis of La Crosse virus and in vitro and in vivo phenotypes (Q27478428) (← links)
- Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus (Q30229074) (← links)
- Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins (Q30708312) (← links)
- Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines (Q33570326) (← links)
- Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates (Q33604189) (← links)
- Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees (Q33605207) (← links)
- Envelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism. (Q33911962) (← links)
- Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination (Q34075698) (← links)
- Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development (Q34204623) (← links)
- Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo (Q34228628) (← links)
- Current research on respiratory viral infections: Third International Symposium (Q34276842) (← links)
- Animal pneumoviruses: molecular genetics and pathogenesis (Q34313560) (← links)
- Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone (Q34328895) (← links)
- Present and future of veterinary viral vaccinology: a review (Q34341579) (← links)
- Respiratory syncytial virus and other pneumoviruses: a review of the international symposium--RSV 2003. (Q34364454) (← links)
- Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies (Q34425648) (← links)
- Determinants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic (Q34465213) (← links)
- Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein (Q34744464) (← links)
- Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years (Q35566601) (← links)
- Respiratory syncytial virus infection: therapy and prevention (Q35674160) (← links)
- Evaluation of pneumonia virus of mice as a possible human pathogen (Q35943578) (← links)
- Carriers for the delivery of a vaccine against respiratory syncytial virus (Q36194078) (← links)
- New generation live vaccines against human respiratory syncytial virus designed by reverse genetics (Q36237057) (← links)
- Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B (Q36453608) (← links)
- Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease (Q36692791) (← links)
- Live-attenuated respiratory syncytial virus vaccines (Q36692801) (← links)
- Understanding the mechanisms of viral induced asthma: new therapeutic directions (Q37072079) (← links)
- Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected] (Q37093418) (← links)
- The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection (Q37123113) (← links)
- A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction (Q37157161) (← links)
- Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV. (Q37348134) (← links)
- The Respiratory Syncytial Virus Phosphoprotein, Matrix Protein, and Fusion Protein Carboxy-Terminal Domain Drive Efficient Filamentous Virus-Like Particle Formation (Q37415410) (← links)
- RNA-based viral vectors (Q38266413) (← links)
- Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis. (Q38660842) (← links)
- Animal models of respiratory syncytial virus infection (Q39026362) (← links)
- Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector (Q39593656) (← links)
- Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response (Q39612134) (← links)
- Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells (Q39752893) (← links)
- Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing (Q39868272) (← links)
- Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals (Q40828974) (← links)
- Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins (Q41890251) (← links)
- Phylogenetic relationships of Brazilian bovine respiratory syncytial virus isolates and molecular homology modeling of attachment glycoprotein (Q45421149) (← links)
- Respiratory syncytial virus vaccine development (Q56481283) (← links)
- Cloning of the transmembrane glycoproteins G and F from a Brazilian isolate of bovine respiratory syncytial virus in a prokaryotic system (Q56797407) (← links)
- Respiratory syncytial virus vaccine development (Q56893551) (← links)
- Mucosal immunization with live recombinant bovine respiratory syncytial virus (BRSV) and recombinant BRSV lacking the envelope glycoprotein G protects against challenge with wild-type BRSV (Q95760881) (← links)